首页> 外文OA文献 >PCN14 Comparative effectiveness of everolimus vs. fulvestrant monotherapy among postmenopausal women with hr+/her2- metastatic breast cancer

【2h】

PCN14 Comparative effectiveness of everolimus vs. fulvestrant monotherapy among postmenopausal women with hr+/her2- metastatic breast cancer

机译：PCN14依维莫司与氟维司群单药治疗在具有hr + / her2转移性乳腺癌的绝经后妇女中的比较有效性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Lin P.L.; Hao Y.; Xie J.; Li N.; Ohashi E.; Koo V.; Wu E.Q.;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Comparative effectiveness of everolimus-based therapy versus endocrine monotherapy among postmenopausal women with HRthorn/HER2- metastatic breast cancer: a retrospective chart review in community oncology practices in the US (vol 31, pg 1095, 2015) [J] . Xie Jipan, Hao Yanni, Li Nanxin, Current medical research and opinion . 2019,第5期

机译：高血症疗法治疗的比较有效性与HHRTHORN / HER2-转移乳腺癌绝经后妇女的内分泌单疗法：美国社区肿瘤学实践的回顾性图表综述（Vol 31，PG 1095,2015）
2. Comparative effectiveness of everolimus-based therapy versus endocrine monotherapy among postmenopausal women with HR+/HER2-metastatic breast cancer: a retrospective chart review in community oncology practices in the US [J] . Xie Jipan, Hao Yanni, Li Nanxin, Current medical research and opinion . 2015,第6期

机译：依维莫司治疗与内分泌单一治疗在HR + / HER2转移性乳腺癌绝经后妇女中的比较有效性：美国社区肿瘤学实践的回顾性图表回顾
3. Health-related quality of life and disease symptoms in postmenopausal women with hr+, her2- advanced breast cancer treated with everolimus plus exemestane versus exemestane monotherapy [J] . CamponeM., BeckJ.T., GnantM., Current medical research and opinion . 2013,第11期

机译：依维莫司联合依西美坦与依西美坦单药治疗的hr +，her2-晚期乳腺癌绝经后妇女的健康相关生活质量和疾病症状
4. Association of bone mineral density and mammographic breast density in premenopausal and postmenopausal Malaysian women: Study on women with and without breast cancer [C] . Norhayati Mohd Zain, Vengkatha Priya Seriramulu, Kanaga Kumari Chelliah, International Conference on Bio-engineering for Smart Technologies . 2016

机译：绝经前和绝经后马来西亚女性的骨矿物质密度与乳房X线照片乳房密度的关系：有无乳腺癌的女性研究
5. A comparative study of quality of life in patients with low-and intermediate-risk prostate cancer treated at a single institution: Stereotactic radiotherapy vs. high dose-rate brachytherapy monotherapy vs. high dose-rate brachytherapy boost [D] . Helou, Joelle. 2017

机译：单一机构治疗的中低危前列腺癌患者生活质量的比较研究：立体定向放疗与高剂量率近距离放射疗法单药疗法与高剂量率近距离放射疗法增强
6. Cost-Effectiveness Analysis of Abemaciclib Plus Fulvestrant in the Second-Line Treatment of Women With HR+/HER2– Advanced or Metastatic Breast Cancer: A US Payer Perspective [O] . Yingcheng Wang, Mingjun Rui, Xin Guan, 2021

机译：ABEMACICLIB加氟斯特朗夫妇在妇女的二线治疗中的成本效益分析及HR + / HER2-先进或转移性乳腺癌：美国付款人的观点
7. 163P Population-adjusted comparison of SOLAR-1 and BOLERO-2: PFS with second-line alpelisib + fulvestrant vs everolimus + exemestane in postmenopausal pts with PIK3CA-mut hormone-receptor positive (HR+) human epidermal growth factor receptor-2 negative (HER2-) advanced breast cancer (ABC) [O] . E.M. Ciruelos, T. Delea, A. Moynahan, 2020

机译：163P人口调整的太阳能-1和Bolero-2的比较：PFS与二线alpelisib +富勒斯特语+ Everolimus + Extemestane在绝经后PTS，PIK3CA-MUT激素受体阳性（HR +）人体表皮生长因子受体-2阴性（HER2 - ）晚期乳腺癌（ABC）

PCN14 Comparative effectiveness of everolimus vs. fulvestrant monotherapy among postmenopausal women with hr+/her2- metastatic breast cancer

著录项

引文网络

相似文献

相关主题

期刊订阅